These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25983181)

  • 1. The EuroIntervention coronary bifurcation treatment supplement.
    Stankovic G; Lassen JF; Hildick-Smith D; Lefèvre T; Louvard Y; Gwon HC; Grundeken MJ
    EuroIntervention; 2015; 11 Suppl V():V9-11. PubMed ID: 25983181
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresorbable Scaffold With Drug-Coated Balloon: A "Biodegradable" Model for Bifurcation Lesions Treatment. The New Intriguing Chapter of the "Leaving Nothing Behind" Saga.
    Buccheri D; Piraino D; Andolina G
    Am J Cardiol; 2016 Jul; 118(2):308-9. PubMed ID: 27206913
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioresorbable vascular scaffolds for left main lesions; a novel strategy to overcome limitations.
    Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
    Int J Cardiol; 2014 Jul; 175(1):e11-3. PubMed ID: 24845788
    [No Abstract]   [Full Text] [Related]  

  • 5. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
    Danson E; Bhindi R; Hansen P
    Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioresorbable Vascular Scaffolds in Coronary Bifurcation Lesions: Only in Expert Hands.
    Colleran R; Byrne RA
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):543-6. PubMed ID: 27157886
    [No Abstract]   [Full Text] [Related]  

  • 7. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous coronary intervention: balloons, stents and scaffolds.
    Colleran R; Kastrati A
    Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When and how to use BRS in bifurcations?
    Stankovic G; Lassen JF
    EuroIntervention; 2015; 11 Suppl V():V185-7. PubMed ID: 25983163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
    Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary intervention in 2015: Improvement of long-term outcomes after PCI.
    Zeymer U
    Nat Rev Cardiol; 2016 Feb; 13(2):69-70. PubMed ID: 26763540
    [No Abstract]   [Full Text] [Related]  

  • 12. What about the risk of thrombosis with bioresorbable scaffolds?
    Capodanno D; Joner M; Zimarino M
    EuroIntervention; 2015; 11 Suppl V():V181-4. PubMed ID: 25983162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery aneurysms formation within Everolimus-eluting stents and bioresorbable vascular scaffolds.
    Lee WC; Chung WJ; Fang HY; Wu CJ
    Int J Cardiol; 2016 Mar; 206():58-60. PubMed ID: 26774833
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Tanaka A; Jabbour RJ; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First ad hoc bioresorbable vascular scaffold bench test: a glimpse into percutaneous bifurcation interventions.
    Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Gaspardone A
    Int J Cardiol; 2014 Apr; 172(3):604-6. PubMed ID: 24491860
    [No Abstract]   [Full Text] [Related]  

  • 16. Design Principles of Bioresorbable Polymeric Scaffolds.
    Kossuth MB; Perkins LEL; Rapoza RJ
    Interv Cardiol Clin; 2016 Jul; 5(3):349-355. PubMed ID: 28582032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
    Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
    Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete healing of a bifurcation lesion treated with the implantation of 2 bioresorbable vascular scaffolds with the T and small protrusion technique.
    Łanocha M; Lesiak M
    Kardiol Pol; 2019 Apr; 77(4):488-489. PubMed ID: 31025651
    [No Abstract]   [Full Text] [Related]  

  • 19. Self-correction property a novel feature of bioresorbable coronary scaffolds.
    Diletti R; Ligthart JM; Ramdhan R; Van Mieghem NM
    Int J Cardiol; 2016 Jul; 214():417-8. PubMed ID: 27088402
    [No Abstract]   [Full Text] [Related]  

  • 20. Paving the way to a bioresorbable technology: Development of the absorb BRS program.
    Perkins LE; Kossuth MB; Fox JC; Rapoza RJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):1-9. PubMed ID: 27797462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.